26 Nov 2024 UPCOMING [Jan 29] TI Best Evidence Webinar: Addressing medications that are ineffective and potentially harmful for patients with alcohol and other substance use disorders
In this TI Best Evidence webinar, Dr. Evan Wood will raise awareness of evidence-based interventions included in a new national guideline for the clinical management of high-risk drinking and alcohol use disorder, highlight the difference between evidence-based and common non-evidence-based interventions (including routine antidepressant use) that impact care of this population, and help participants understand the applicability of these recommendations to persons with other substance use disorders.
TITLE: Addressing medications that are ineffective and potentially harmful for patients with alcohol and other substance use disorders
WHEN: Wednesday, January 29th, 2025 at 12:00 PM PST [convert to your local time]
WHERE: This is a free online webinar. After you register you will receive a confirmation email including connection details.
SPEAKER: Dr. Evan Wood, Professor of Medicine, Canada Research Chair in Addiction Medicine, Faculty of Medicine, University of British Columbia.
CME CREDITS: MainPro+/MOC Section 1 credits: 1.0. Those who register, attend the webinar and complete the evaluation will receive their certificate.
REGISTRATION: https://ubc.zoom.us/meeting/register/u5EkduChpjsuG9V5YEiTma-RoSu_za-f4yZB
LEARNING OBJECTIVES (by the end of this session, participants will be able to):
- Demonstrate increased awareness of evidence-based interventions included in a new national guideline for the clinical management of high-risk drinking and alcohol use disorder.
- Understand the difference between evidence-based and common non-evidence-based interventions (including routine antidepressant use) that impact care of this population.
- Understand the applicability of these recommendations to persons with other substance use disorders.
About the topic: Persons with alcohol and other substance use disorders commonly present with symptoms and mental wellness concerns such as insomnia, anxiety and low mood. As a result, a range of medications, such as antidepressants and antipsychotics, are commonly used to address symptoms either attributed to substance use or secondary to underlying concurrent mental health conditions. Despite this widespread approach to clinical care, an under-appreciated literature demonstrates that this pattern of prescribing is likely ineffective for most patients, and there is also an under-appreciated literature demonstrating how certain medications appear to have an under-appreciated adverse event profile resulting in increased substance use.
About the speaker: Dr. Evan Wood, MD, PhD, FRCPC is a Professor of Medicine at the University of British Columbia, where he holds a Canada Research Chair in Addiction Medicine. Dr. Wood is an addiction medicine physician who has helped with the leadership of a number of clinical care and clinical training programs and has co-chaired the writing of a number of provincial and national substance use disorder therapeutic guidelines aimed at improving care of persons with substance use disorder.
No Comments